Patent · 2025 · pending
Treatment of PLG Related Diseases and Disorders
siRNA and antisense oligonucleotides targeting PLG, for conditions associated with PLG mutations.
- Filings
- 1
- Status
- Pending
- First priority
- Jan 28, 2025
Patent · 2025 · pending
siRNA and antisense oligonucleotides targeting PLG, for conditions associated with PLG mutations.